These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 32344220
1. Sensitivity and specificity of cerebrospinal fluid CXCL13 for diagnosing Lyme neuroborreliosis - a study on 1410 patients and review of the literature. Lintner H, Hochgatterer-Rechberger P, Pischinger B, Seier J, Vollmann P, Haushofer A, Rittner H, Sommer C, Topakian R. J Neurol Sci; 2020 Jul 15; 414():116843. PubMed ID: 32344220 [Abstract] [Full Text] [Related]
5. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children. Barstad B, Tveitnes D, Noraas S, Selvik Ask I, Saeed M, Bosse F, Vigemyr G, Huber I, Øymar K. Pediatr Infect Dis J; 2017 Dec 15; 36(12):e286-e292. PubMed ID: 28661964 [Abstract] [Full Text] [Related]
6. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis. Henningsson AJ, Lager M, Brännström R, Tjernberg I, Skogman BH. Eur J Clin Microbiol Infect Dis; 2018 Oct 15; 37(10):1983-1991. PubMed ID: 30083887 [Abstract] [Full Text] [Related]
7. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis. Henningsson AJ, Gyllemark P, Lager M, Skogman BH, Tjernberg I. APMIS; 2016 Nov 15; 124(11):985-990. PubMed ID: 27651242 [Abstract] [Full Text] [Related]
8. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation. Hytönen J, Kortela E, Waris M, Puustinen J, Salo J, Oksi J. J Neuroinflammation; 2014 Jun 11; 11():103. PubMed ID: 24920219 [Abstract] [Full Text] [Related]
9. [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine]. Rupprecht TA, Lechner C, Tumani H, Fingerle V. Nervenarzt; 2014 Apr 11; 85(4):459-64. PubMed ID: 24682168 [Abstract] [Full Text] [Related]
10. The Usefulness of Two CXCL13 Assays on Cerebrospinal Fluid for the Diagnosis of Lyme Neuroborreliosis: a Retrospective Study in a Routine Clinical Setting. van Gorkom T, van Arkel GHJ, Heron M, Voet W, Thijsen SFT, Kremer K. J Clin Microbiol; 2021 Aug 18; 59(9):e0025521. PubMed ID: 34132584 [Abstract] [Full Text] [Related]
11. The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study. Knudtzen FC, Nilsson AC, Hovius JW, Skarphedinsson S. Eur J Clin Microbiol Infect Dis; 2020 Aug 18; 39(8):1461-1470. PubMed ID: 32172371 [Abstract] [Full Text] [Related]
12. Comparative Analysis of the Euroimmun CXCL13 Enzyme-Linked Immunosorbent Assay and the ReaScan Lateral Flow Immunoassay for Diagnosis of Lyme Neuroborreliosis. Ziegler K, Rath A, Schoerner C, Meyer R, Bertsch T, Erbguth F, Bogdan C, Steinmann J, Held J. J Clin Microbiol; 2020 Aug 24; 58(9):. PubMed ID: 32434781 [Abstract] [Full Text] [Related]
13. CSF B - lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. Ljøstad U, Mygland Å. J Neurol; 2008 May 24; 255(5):782. PubMed ID: 27517589 [Abstract] [Full Text] [Related]
16. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables. Barstad B, Tveitnes D, Dalen I, Noraas S, Ask IS, Bosse FJ, Øymar K. Infect Dis (Lond); 2019 May 24; 51(11-12):856-863. PubMed ID: 31573360 [Abstract] [Full Text] [Related]